Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
27.70
-0.10 (-0.36%)
At close: Mar 20, 2026, 4:00 PM EDT
28.40
+0.70 (2.51%)
After-hours: Mar 20, 2026, 7:44 PM EDT

Roivant Sciences Revenue

Roivant Sciences had revenue of $2.00M in the quarter ending December 31, 2025, a decrease of -77.83%. This brings the company's revenue in the last twelve months to $13.31M, down -56.36% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$13.31M
Revenue Growth
-56.36%
P/S Ratio
1,489.48
Revenue / Employee
$17,747
Employees
750
Market Cap
19.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M--